Phase I trial of adoptive immunotherapy of cancer patients using monocyte-derived macrophages activated with interferon γ and lipopolysaccharide.

MLA

Hennemann, Burkhard, et al. “Phase I Trial of Adoptive Immunotherapy of Cancer Patients Using Monocyte-Derived Macrophages Activated with Interferon γ and Lipopolysaccharide.” Cancer Immunology, Immunotherapy, vol. 45, no. 5, Dec. 1997, pp. 250–56. EBSCOhost, https://doi.org/10.1007/PL00006671.

APA

Hennemann, B., Beckmann, G., Eichelmann, A., Rehm, A., & Andreesen, R. (1997). Phase I trial of adoptive immunotherapy of cancer patients using monocyte-derived macrophages activated with interferon γ and lipopolysaccharide. Cancer Immunology, Immunotherapy, 45(5), 250–256. https://doi.org/10.1007/PL00006671

Chicago

Hennemann, Burkhard, Gabriele Beckmann, Annette Eichelmann, Annegret Rehm, and R. Andreesen. 1997. “Phase I Trial of Adoptive Immunotherapy of Cancer Patients Using Monocyte-Derived Macrophages Activated with Interferon γ and Lipopolysaccharide.” Cancer Immunology, Immunotherapy 45 (5): 250–56. doi:10.1007/PL00006671.